Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin Alfa in Idiopathic Anemia of Aging
NCT00104169Phase 2Terminated
- Sponsor
- National Institute on Aging
- Start
- Aug 2004
- Primary completion
- May 2007
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 2 trial of epoetin alfa in idiopathic aplastic anemia, sponsored by National Institute on Aging. Started Aug 2004; status: terminated.
02
Drugs
epoetin alfa
03
Conditions
idiopathic aplastic anemia
Beyond the preview
Go deeper on NCT00104169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00104169.